Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Prajwal Chaitanya Boddu & Tapan Mahendra Kadia. (2017) Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review. Expert Review of Hematology 10:5, pages 433-448.
Read now
Read now
Daria V. Babushok, Monica Bessler & Timothy S. Olson. (2016) Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leukemia & Lymphoma 57:3, pages 520-536.
Read now
Read now
Pietro Merli, Luisa Strocchio, Luciana Vinti, Giuseppe Palumbo & Franco Locatelli. (2015) Eltrombopag for treatment of thrombocytopenia-associated disorders. Expert Opinion on Pharmacotherapy 16:14, pages 2243-2256.
Read now
Read now
Jennifer Rhodes, Adam Amsterdam, Takaomi Sanda, Lisa A. Moreau, Keith McKenna, Stefan Heinrichs, Neil J. Ganem, Karen W. Ho, Donna S. Neuberg, Adam Johnston, Yebin Ahn, Jeffery L. Kutok, Robert Hromas, Justin Wray, Charles Lee, Carly Murphy, Ina Radtke, James R. Downing, Mark D. Fleming, Laura E. MacConaill, James F. Amatruda, Alejandro Gutierrez, Ilene Galinsky, Richard M. Stone, Eric A. Ross, David S. Pellman, John P. Kanki & A. Thomas Look. (2009) Emi1 Maintains Genomic Integrity during Zebrafish Embryogenesis and Cooperates with p53 in Tumor Suppression. Molecular and Cellular Biology 29:21, pages 5911-5922.
Read now
Read now
Joyce J Ou & Adam Bagg. (2009) Diagnostic challenges in the myelodysplastic syndromes: the current and future role of genetic and immunophenotypic studies. Expert Opinion on Medical Diagnostics 3:3, pages 275-291.
Read now
Read now
Articles from other publishers (62)
Wendy Cuccuini, Marie-Agnes Collonge-Rame, Nathalie Auger, Nathalie Douet-Guilbert, Lucie Coster & Marina Lafage-Pochitaloff. (2023) Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH). Current Research in Translational Medicine 71:4, pages 103423.
Crossref
Crossref
Tuphan Kanti Dolai, Manisha Jain & Manoranjan Mahapatra. (2022) Idiopathic Aplastic anemia: Indian Perspective. Indian Journal of Hematology and Blood Transfusion 39:3, pages 357-370.
Crossref
Crossref
Jianping Li, Xu Liu, Xin Zhao, Wenrui Yang, Li Zhang, Liping Jing, Kang Zhou, Lei Ye, Yuan Li, Yang Li, Guangxin Peng, Lin Song, Huihui Fan, Xiangrong Hu, Xiaoxia Li & Fengkui Zhang. (2023) Long‐term outcomes of aplastic anemia with cytogenetic abnormalities at diagnosis. European Journal of Haematology 110:4, pages 379-385.
Crossref
Crossref
Qi Liu, Huijie Dong, Yuzhu Li, Yingying Shen, Yilei Hong, Ying Chen, Shan Liu, Xiaolian Wu, Wenbin Liu, Huijin Hu, Yuechao Zhao, Shenyun Lin, Yiping Shen, Yuhong Zhou, Baodong Ye & Dijiong Wu. (2022) Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study. Lipids in Health and Disease 21:1.
Crossref
Crossref
Jibran Durrani & Emma M. Groarke. (2022) Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation. Seminars in Hematology 59:3, pages 137-142.
Crossref
Crossref
Zhong-jian Wang, Hong-bo Chen, Fen Zhou, Hui Yu, Xiao-yan Wu, Ya-qing Shen, Yi-ning Qiu & Run-ming Jin. (2022) A New Immunosuppressive Therapy for Very Severe Aplastic Anemia in Children with Autoantibodies. Current Medical Science 42:2, pages 379-386.
Crossref
Crossref
Guangxin Peng, Guangsheng He, Hong Chang, Sujun Gao, Xinjian Liu, Tong Chen, Pei Li, Bing Han, Miao Miao, Zheng Ge, Xiaoyan Ge, Fei Li, Yingmei Li, Shunqing Wang, Yi Wang, Yaqi Shen, Tao Zhang, Jianjun Zou & Fengkui Zhang. (2022) A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy. Therapeutic Advances in Hematology 13, pages 204062072210851.
Crossref
Crossref
Beatrice Drexler & Jakob Passweg. (2021) Current evidence and the emerging role of eltrombopag in severe aplastic anemia. Therapeutic Advances in Hematology 12, pages 204062072199812.
Crossref
Crossref
Pınar KOŞAR, Muhammet Yusuf TEPEBAŞI & Emine Güçhan ALANOĞLU. (2020) Evaluation of conventional cytogenetic, molecular cytogenetics and molecular genetics results in hematological malignancesHematolojik malignitelerde konvansiyonel sitogenetik, moleküler sitogenetik ve moleküler genetik sonuçlarının değerlendirilmesi. SDÜ Tıp Fakültesi Dergisi 27:4, pages 547-554.
Crossref
Crossref
Katarzyna Brzeźniakiewicz-Janus, Joanna Rupa-Matysek & Lidia Gil. (2020) Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells. Stem Cell Reviews and Reports 16:3, pages 472-481.
Crossref
Crossref
Jun Li, Wendy Dubois, Vishal Thovarai, Zhijie Wu, Xingmin Feng, Tyler Peat, Shuling Zhang, Shurjo K. Sen, Giorgio Trinchieri, Jichun Chen, Beverly A. Mock & Neal S. Young. (2020) Attenuation of immune‐mediated bone marrow damage in conventionally housed mice. Molecular Carcinogenesis 59:2, pages 237-245.
Crossref
Crossref
Ghadir S. Sasa & Adrianna Vlachos. 2020. Hematology in the Adolescent Female. Hematology in the Adolescent Female
291
307
.
Melisa Ruiz-Gutierrez, Özge Vargel Bölükbaşı, Gabriela Alexe, Adriana G. Kotini, Kaitlyn Ballotti, Cailin E. Joyce, David W. Russell, Kimberly Stegmaier, Kasiani Myers, Carl D. Novina, Eirini P. Papapetrou & Akiko Shimamura. (2019) Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells. JCI Insight 4:12.
Crossref
Crossref
Prajwal C. Boddu & Tapan M. Kadia. (2018) Molecular pathogenesis of acquired aplastic anemia. European Journal of Haematology 102:2, pages 103-110.
Crossref
Crossref
Neal S. Young. (2018) Aplastic Anemia. New England Journal of Medicine 379:17, pages 1643-1656.
Crossref
Crossref
Phuong L. Nguyen & Robert Paul Hasserjian. 2018. Hematopathology. Hematopathology
539
563.e2
.
Yigal Dror & Michaela Cada. 2018. Bone Marrow Failure. Bone Marrow Failure
25
55
.
Natasha Stanley, Timothy S. Olson & Daria V. Babushok. (2017) Recent advances in understanding clonal haematopoiesis in aplastic anaemia. British Journal of Haematology 177:4, pages 509-525.
Crossref
Crossref
Amy S. Duffield & Amy E. DeZern. 2017. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer
793
815
.
Roberta Sandra da Silva Tanizawa, Maria Claudia Nogueira Zerbini, Ricardo Rosenfeld, Cristina Aiko Kumeda, Raymundo Soares Azevedo, Sheila Aparecida Coelho Siqueira & Elvira Deolinda Rodrigues Pereira Velloso. (2017) Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis. Revista Brasileira de Hematologia e Hemoterapia 39:1, pages 4-12.
Crossref
Crossref
Claudio Fozza, Valeria Crobu, Maria Antonia Isoni & Fausto Dore. (2016) The immune landscape of myelodysplastic syndromes. Critical Reviews in Oncology/Hematology 107, pages 90-99.
Crossref
Crossref
Sohita Dhillon & Paul L. McCormack. (2016) Eltrombopag in severe aplastic anaemia: a guide to its use in the EU. Drugs & Therapy Perspectives 32:6, pages 232-237.
Crossref
Crossref
Paul L. McCormack. (2015) Eltrombopag: A Review of Its Use in Patients with Severe Aplastic Anaemia. Drugs 75:5, pages 525-531.
Crossref
Crossref
Ronan Desmond, Danielle M. Townsley, Cynthia Dunbar & Neal S. Young. (2015) Eltrombopag in Aplastic Anemia. Seminars in Hematology 52:1, pages 31-37.
Crossref
Crossref
Ronan DesmondDanielle M. TownsleyBogdan DumitriuMatthew J. OlnesPhillip ScheinbergMargaret BevansAnkur R. ParikhKinneret BroderKatherine R. Calvo, Colin O. Wu, Neal S. YoungCynthia E. Dunbar. (2014) Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood 123:12, pages 1818-1825.
Crossref
Crossref
Daria V. Babushok, Hongbo M. Xie, Jacquelyn J. Roth, Nieves Perdigones, Timothy S. Olson, Joshua D. Cockroft, Xiaowu Gai, Juan C. Perin, Yimei Li, Michele E. Paessler, Hakon Hakonarson, Gregory M. Podsakoff, Philip J. Mason, Jaclyn A. Biegel & Monica Bessler. (2014) Single nucleotide polymorphism array analysis of bone marrow failure patients reveals characteristic patterns of genetic changes. British Journal of Haematology 164:1, pages 73-82.
Crossref
Crossref
Danielle M. Townsley, Ronan Desmond, Cynthia E. Dunbar & Neal S. Young. (2013) Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes. International Journal of Hematology 98:1, pages 48-55.
Crossref
Crossref
Claudio Fozza & Maurizio Longinotti. (2013) The role of T-cells in the pathogenesis of myelodysplastic syndromes: Passengers and drivers. Leukemia Research 37:2, pages 201-203.
Crossref
Crossref
Wei‐Gang Tong, Alfonso Quintás‐Cardama, Tapan Kadia, Gautam Borthakur, Elias Jabbour, Farhad Ravandi, Stefan Faderl, William Wierda, Sherry Pierce, Jianqin Shan, Carlos Bueso‐Ramos, Hagop Kantarjian & Guillermo Garcia‐Manero. (2012) Predicting survival of patients with hypocellular myelodysplastic syndrome. Cancer 118:18, pages 4462-4470.
Crossref
Crossref
Irith Baumann, Monika Führer, Sonja Behrendt, Vit Campr, Judit Csomor, Ingrid Furlan, Valérie de Haas, Gitte Kerndrup, Roos J Leguit, Pascale De Paepe, Peter Noellke, Charlotte Niemeyer & Stephan Schwarz. (2012) Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria. Histopathology 61:1, pages 10-17.
Crossref
Crossref
Claudio Fozza & Maurizio Longinotti. (2012) Are T‐cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes?. European Journal of Haematology 88:5, pages 380-387.
Crossref
Crossref
Valeria Visconte & Ramon V. Tiu. 2012. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer
637
646
.
Adina M. Cioc & Phuong L. Nguyen. 2012. Hematopathology. Hematopathology
523
546
.
James R. Cook. 2012. Hematopathology. Hematopathology
160
176
.
Zeba N. Singh & Margaret L. Gulley. 2012. Pediatric Neoplasia. Pediatric Neoplasia
75
100
.
W Wang, X Wang, X Xu & G Lin. (2011) Diagnosis and Treatment of Acquired Aplastic Anaemia in Adults: 142 Cases from a Multicentre, Prospective Cohort Study in Shanghai, China. Journal of International Medical Research 39:5, pages 1994-2005.
Crossref
Crossref
Manuel G. AfableIIII, Marcin Wlodarski, Hideki MakishimaMohammed Shaik, Mikkael A. Sekeres, Ramon V. Tiu, Matt Kalaycio, Christine L. O'KeefeJaroslaw P. Maciejewski. (2011) SNP array–based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood 117:25, pages 6876-6884.
Crossref
Crossref
EC Gordon-Smith. 2011. Blood and Bone Marrow Pathology. Blood and Bone Marrow Pathology
213
224
.
C. C. YIN, L. J. MEDEIROS & C. E. BUESO‐RAMOS. (2010) REVIEW: Recent advances in the diagnosis and classification of myeloid neoplasms – comments on the 2008 WHO classification. International Journal of Laboratory Hematology 32:5, pages 461-476.
Crossref
Crossref
Joo Won ChungJae Hee Cheon, Kyong Joo LeeJin Seok KimSeon-Jung JangWoo Ick YangTae Il KimWon Ho Kim. (2010) Aplastic Anemia with Trisomy 8 and Trisomy 9 in Intestinal Behçet's Disease. The Korean Journal of Gastroenterology 55:4, pages 256.
Crossref
Crossref
H. J. HUH, S. L. CHAE, M. LEE, K. S. HONG, Y. C. MUN, C. M. SEONG, W. S. CHUNG & J. W. HUH. (2009) CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome. International Journal of Laboratory Hematology 31:3, pages 344-351.
Crossref
Crossref
Eva C. Guinan. (2009) Acquired Aplastic Anemia in Childhood. Hematology/Oncology Clinics of North America 23:2, pages 171-191.
Crossref
Crossref
Grover C. Bagby & Gabrielle Meyers. (2009) Myelodysplasia and Acute Leukemia as Late Complications of Marrow Failure: Future Prospects for Leukemia Prevention. Hematology/Oncology Clinics of North America 23:2, pages 361-376.
Crossref
Crossref
Vikas Gupta & Judith Marsh. 2009. Hematopoietic Stem Cell Transplantation in Clinical Practice. Hematopoietic Stem Cell Transplantation in Clinical Practice
165
176
.
Anil Kumar Tripathi, Payal Tripathi, Ashutosh Kumar, Rizwan Ahmad, Raj K. Singh, Anil K. Balapure & Achchhe L. Vishwakerma. (2008) S-phase fraction as a useful marker for prognosis and therapeutic response in patients with aplastic anemia. Hematology/Oncology and Stem Cell Therapy 1:4, pages 216-220.
Crossref
Crossref
Neal S Young, Phillip Scheinberg & Rodrigo T Calado. (2008) Aplastic anemia. Current Opinion in Internal Medicine 7:4, pages 338-344.
Crossref
Crossref
Neal S Young, Phillip Scheinberg & Rodrigo T Calado. (2008) Aplastic anemia. Current Opinion in Hematology 15:3, pages 162-168.
Crossref
Crossref
Goran Cuturilo, Dejan Skoric, Slobodanka Miletic Grkovic, Vladislav Bojic, Predrag Rodic & Igor Stefanovic. (2008) Aplastic anemia and Turner syndrome. Cancer Genetics and Cytogenetics 180:2, pages 158-159.
Crossref
Crossref
Faramarz Naeim, P. Nagesh Rao & Wayne W. Grody. 2008. Hematopathology. Hematopathology
115
127
.
Sergej Konoplev, L. Jeffrey Medeiros, Patrick A. Lennon, Sapana Prajapati, Anuradha Kanungo & Pei Lin. (2007) Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia. Cancer 110:7, pages 1520-1526.
Crossref
Crossref
R Tiu, L Gondek, C O'Keefe & J P Maciejewski. (2007) Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes. Leukemia 21:8, pages 1648-1657.
Crossref
Crossref
Grover C. Bagby & Gabrielle Meyers. (2007) Bone Marrow Failure as a Risk Factor for Clonal Evolution: Prospects for Leukemia Prevention. Hematology 2007:1, pages 40-46.
Crossref
Crossref
Robert J. Arceci. 2007. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia
345
372
.
Michelle M. Dolan, Timothy P. Singleton, Joseph Neglia & Adina Cioc. (2006) Aplastic Anemia and Monosomy 7–Associated Dysmegakaryocytopoiesis. American Journal of Clinical Pathology 126:6, pages 925-930.
Crossref
Crossref
Neal S. YoungRodrigo T. CaladoPhillip Scheinberg. (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108:8, pages 2509-2519.
Crossref
Crossref
Juliana Teo & Yigal Dror. 2006. Pediatric Hematology. Pediatric Hematology
64
76
.
W H Matsui, R A Brodsky, B D Smith, M J Borowitz & R J Jones. (2006) Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes. Leukemia 20:3, pages 458-462.
Crossref
Crossref
Weihua ZengAkira MiyazatoGuibin ChenSachiko KajigayaNeal S. YoungJaroslaw P. Maciejewski. (2006) Interferon-γ-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood 107:1, pages 167-175.
Crossref
Crossref
James W. Vardiman. (2006) Hematopathological Concepts and Controversies in the Diagnosis and Classification of Myelodysplastic Syndromes. Hematology 2006:1, pages 199-204.
Crossref
Crossref
Jaroslaw P. Maciejewski & Antonio M. Risitano. (2005) Aplastic Anemia: Management of Adult Patients. Hematology 2005:1, pages 110-117.
Crossref
Crossref
Richard E. Kast & Eric Lewin Altschuler. (2005) Proposal for using small molecule tumor necrosis factor-alpha lowering agents, possibly bupropion, in aplastic anemia. Medical Hypotheses 65:2, pages 374-376.
Crossref
Crossref
Jaroslaw P Maciejewski & Antonio Risitano. (2003) Hematopoietic stem cells in aplastic anemia. Archives of Medical Research 34:6, pages 520-527.
Crossref
Crossref